Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report

BACKGROUND: Immune checkpoint inhibitors (ICIs), an enormous oncological breakthrough in the last 10 years, have become the standard treatments for several types of solid cancers. Although ICIs are generally well tolerated and result in favorable outcomes, they also cause unique immune-related adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Guihuan, Li, Suyang, Li, Bingliang, Yang, Qingqing, Deng, Haiyi, Yang, Yilin, Xie, Xiaohong, Lin, Xinqing, Seki, Nobuhiko, Miura, Satoru, Shukuya, Takehito, Zhou, Chengzhi, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
iMDT Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742628/
https://www.ncbi.nlm.nih.gov/pubmed/36519029
http://dx.doi.org/10.21037/tlcr-22-745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742628/
https://www.ncbi.nlm.nih.gov/pubmed/36519029
http://dx.doi.org/10.21037/tlcr-22-745

Ejemplares similares